Novolog Pharm Operating Margin vs. Revenue

NVLG Stock   169.90  0.50  0.30%   
Taking into consideration Novolog Pharm's profitability measurements, Novolog Pharm Up 1966 may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Novolog Pharm's ability to earn profits and add value for shareholders.
For Novolog Pharm profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Novolog Pharm to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Novolog Pharm Up 1966 utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Novolog Pharm's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Novolog Pharm Up 1966 over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Novolog Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novolog Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novolog Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Novolog Pharm Up Revenue vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Novolog Pharm's current stock value. Our valuation model uses many indicators to compare Novolog Pharm value to that of its competitors to determine the firm's financial worth.
Novolog Pharm Up 1966 is considered to be number one stock in operating margin category among its peers. It also is rated top company in revenue category among its peers totaling about  23,683,924,528  of Revenue per Operating Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Novolog Pharm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Novolog Pharm's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Novolog Revenue vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Novolog Pharm

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
0.05 %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Novolog Pharm

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
1.26 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Novolog Revenue vs Competition

Novolog Pharm Up 1966 is rated top company in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 14.48 Billion. Novolog Pharm holds roughly 1.26 Billion in revenue claiming about 9% of equities under Health Care industry.

Novolog Pharm Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Novolog Pharm, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Novolog Pharm will eventually generate negative long term returns. The profitability progress is the general direction of Novolog Pharm's change in net profit over the period of time. It can combine multiple indicators of Novolog Pharm, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Novolog Ltd operates as a health logistics company in Israel. Novolog Ltd operates as a subsidiary of Pharm-Up Ltd. Novolog Ltd operates under Medical Care classification in Israel and is traded on Tel Aviv Stock Exchange.

Novolog Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Novolog Pharm. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Novolog Pharm position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Novolog Pharm's important profitability drivers and their relationship over time.

Use Novolog Pharm in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novolog Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novolog Pharm will appreciate offsetting losses from the drop in the long position's value.

Novolog Pharm Pair Trading

Novolog Pharm Up 1966 Pair Trading Analysis

The ability to find closely correlated positions to Novolog Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novolog Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novolog Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novolog Pharm Up 1966 to buy it.
The correlation of Novolog Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Novolog Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Novolog Pharm Up moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Novolog Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Novolog Pharm position

In addition to having Novolog Pharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Air Thematic Idea Now

Air
Air Theme
Companies specializing in air services and air delivery. The Air theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Air Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Novolog Stock

To fully project Novolog Pharm's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Novolog Pharm Up at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Novolog Pharm's income statement, its balance sheet, and the statement of cash flows.
Potential Novolog Pharm investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Novolog Pharm investors may work on each financial statement separately, they are all related. The changes in Novolog Pharm's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Novolog Pharm's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.